Enhanced Stability of Urokinase‐Type Plasminogen Activator mRNA in Metastatic Breast Cancer MDA‐MB‐231 Cells and LLC‐PK1 Cells Down‐Regulated for Protein Kinase C — Correlation with Cytoplasmic Heterogeneous Nuclear Ribonucleoprotein C
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In LLC‐PK 1 cells, urokinase‐type plasminogen activator (uPA) mRNA has a short half‐life of 70 min. We have previously demonstrated that most of the regulatory regions responsible for the rapid turnover of uPA mRNA in LLC‐PK 1 cells reside in its 3′ untranslated region (3′ UTR), where there are at least three regulatory sites, one of which is A+U‐rich. This A+U‐rich sequence mediates uPA mRNA stabilization induced by protein kinase C (PKC) down‐regulation. In this work, we found that uPA mRNA is rather stable in MDA‐MB‐231 cells with a half‐life of 17 h. We compared the stability of hybrid globin mRNA containing different parts of uPA mRNA in its 3′ UTR and found that the A+U‐rich sequence of uPA mRNA renders otherwise stable globin mRNA unstable in LLC‐PK 1 cells but not in MDA‐MB‐231 cells. We identified a cytoplasmic protein of 40 kDa (p40) which specifically interacts with the A+U‐rich sequence. Levels of p40 activity as detected by ultraviolet cross‐linking were higher in MDA‐MB‐231 and PKC‐down‐regulated LLC‐PK 1 cells than in untreated LLC‐PK, cells. Prior treatment of the cytoplasm with a specific antibody against heterogeneous nuclear ribonucleoprotein C (hnRNP C) significantly reduced p40 activity. These results suggest a correlation between the A+U‐rich sequence‐dependent uPA mRNA stabilization in vivo and the binding of hnRNP C to the A+U‐rich sequence in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Messenger RNA degradation in eukaryotes
Sachs, A. B. (1993) · Cell · doi:10.1016/0092-8674(93)80043-e · Cited by 846
Cited by
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury
Idell, S. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000057846.21303.ab · Cited by 381
The plasminogen activator system: biology and regulation
Irigoyen, J. P., Muñoz-Cánoves, P., Montero, L., Koziczak, M., & Nagamine, Y. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000615 · Cited by 368
Self-citationThe urokinase plasminogen activator system: a target for anti-cancer therapy
Ulisse, S., Baldini, E., Sorrenti, S., & D'Armiento, M. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787314002 · Cited by 312
Tran, H., Maurer, F., & Nagamine, Y. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7177-7188.2003 · Cited by 217
“globin ARE or pCMV– -globin–Xho (50) with HindIII-SalI and inserted into”
BackgroundSelf-citationModulation of mRNA stability as a novel therapeutic approach
Eberhardt, W., Doller, A., Akool, E.-S., & Pfeilschifter, J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.002 · Cited by 173
Metadata
- Authors
- Nanbu, R., Montero, L., D'orazio, D., & Nagamine, Y.
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 1997-07
- Volume
- 247
- Issue
- 1
- Pages
- 169-174
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W2069191293
- Cited by
- 40
- References
- 1
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhanced Stability of Urokinase‐Type Plasminogen Activator mRNA in Metastatic Breast Cancer MDA‐MB‐231 Cells and LLC‐PK1 Cells Down‐Regulated for Protein Kinase C — Correlation with Cytoplasmic Heterogeneous Nuclear Ribonucleoprotein C. https://app.cochat.ai/papers/10.1111/j.1432-1033.1997.00169.x
- The paper
- Nanbu, R., Montero, L., D'orazio, D., & Nagamine, Y. (1997). Enhanced Stability of Urokinase‐Type Plasminogen Activator mRNA in Metastatic Breast Cancer MDA‐MB‐231 Cells and LLC‐PK1 Cells Down‐Regulated for Protein Kinase C — Correlation with Cytoplasmic Heterogeneous Nuclear Ribonucleoprotein C. European Journal of Biochemistry. https://doi.org/10.1111/j.1432-1033.1997.00169.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.